为保障患者安全,心内一科第一时间联系肾病科、ICU等科室开展多学科会诊。经过综合研判,专家团队 决定将周大姨转入ICU病房,实施连续性床旁血液净化治疗,同时严密监测心功能变化。 经过精心治疗,周大姨的心衰症状明显改善,生命体征逐渐平稳,顺利转回普通病房继续治疗。 这场跨越急诊科、心内科、ICU、肾病科、介入中心等多个科室的救治,正是荣成市人民医院多学科协作 (MDT)模式的生动实践,通过整合优质医疗资源,打破学科壁垒,为危重患者搭建起高效、精准的救治通道, 最大限度保障了患者的术前、术中、术后安全。 (李煜) 近日,64岁的周大姨(化名)在荣成市人民医院康复出院,想起这段惊心动魄的救治经历,她和家人满怀感激, 连连向医护人员致谢。 2025年11月中旬的一个凌晨,睡梦中的周大姨突然被剧烈的胸痛惊醒,疼痛持续不缓解,家人见状就近将她 送往荣成市中医院。心电图检查提示心肌酶谱、心衰指标均显著增高,情况危急。荣成市中医院立即启 动荣成胸痛中心联盟救治流程,120急救车火速将周大姨转诊至荣成市人民医院急诊科。 作为荣成胸痛中心联盟的核心单位,荣成市人民医院对高危胸痛患者的救治早已形成成熟的快速响应机 制。急诊科与心内 ...

Core Insights - The establishment of a specialized animal injury outpatient clinic at Jiangnan University Affiliated Hospital has addressed a growing public health issue, treating over 300 patients in its first month due to animal bites and scratches [2][3]. Group 1: Public Health Concerns - Animal injuries, particularly from dogs, cats, and rodents, pose significant health risks, including potential infections and diseases such as rabies, which has a nearly 100% fatality rate once symptoms appear [3]. - The outpatient clinic provides comprehensive care, including wound cleaning, surgical debridement, infection control, and vaccination, ensuring that patients receive timely and professional medical assistance after animal-related injuries [2][3]. Group 2: Medical Treatment and Collaboration - The clinic employs a multidisciplinary team (MDT) approach to enhance wound care, focusing on meticulous treatment of injuries and promoting faster healing through a "three-step wound management" process [5]. - In addition to animal injuries, the clinic also addresses various acute and chronic wounds, offering extended services through "Internet + nursing" to provide quality care at home for patients [5].

Core Viewpoint - The successful surgery of a newborn with a rare congenital heart disease in Changzhou highlights the region's strong medical capabilities and collaborative healthcare system in managing complex critical conditions [1][12]. Group 1: Prenatal Diagnosis and Preparation - During prenatal check-ups, doctors at Changzhou Seventh People's Hospital identified potential heart abnormalities, suspecting complete transposition of the great arteries, a severe condition with low incidence but high risk [3]. - The hospital initiated a preemptive plan, coordinating with the pediatric cardiac team at Changzhou Children's Hospital to ensure seamless transfer and treatment immediately after birth [3]. Group 2: Multidisciplinary Intervention - After birth, the newborn exhibited critically low oxygen levels, prompting an immediate response from the pediatric team and ambulance to transfer the infant to the cardiac center [5]. - A multidisciplinary consultation was organized, involving neonatology, cardiology, anesthesia, critical care, and medical imaging specialists, leading to a decision to maintain life support with medication while preparing for surgery [5]. Group 3: Surgical Procedure - The surgery commenced on December 10, requiring precise anesthesia management and a skilled surgical team led by the deputy director of the cardiac center [7]. - The operation involved complex procedures such as repositioning the great arteries, transplanting coronary arteries, repairing atrial septal defects, and ligating the ductus arteriosus, successfully restoring normal blood circulation within four hours [7]. Group 4: Postoperative Care - Post-surgery, the infant was transferred to the Intensive Care Unit (ICU) for continuous monitoring and treatment, ensuring robust support for heart function recovery [9]. - After two days, the infant's condition stabilized, allowing for a successful chest closure surgery, followed by a positive recovery in the cardiac center [9]. Group 5: Regional Medical Strength - The successful surgery is a testament to the pediatric critical care capabilities in Changzhou, showcasing the effectiveness of the multidisciplinary collaboration model in addressing complex diseases [12][18]. - The region's healthcare system, under the coordination of local health authorities, has established an efficient "life protection chain" for critically ill congenital heart disease patients, from prenatal diagnosis to rapid inter-hospital transfer and multidisciplinary treatment [12].

Core Insights - The blue paper titled "Cognitive Understanding of Public Health Weight Loss and Scientific Medication" was released, highlighting the public's understanding and behavior regarding obesity and weight loss [1][2] - The report indicates that obesity is a significant public health challenge affecting national health quality and increasing the burden on the healthcare system [2][3] Group 1: Public Awareness and Misconceptions - The blue paper reveals that there is a prevalence of "pseudo-science" knowledge regarding weight loss, indicating a need for professional knowledge to break through existing barriers [1] - Many individuals do not recognize obesity as a disease and view weight loss medications as a "shortcut," neglecting the importance of lifestyle interventions [2] - The influence of social media and the "thin is beautiful" concept has led to a proliferation of false weight loss advertisements, contributing to public confusion [2] Group 2: Health Risks and Future Projections - Research shows that without urgent measures, by 2050, 50% of adults and one-third of children and adolescents globally will face overweight or obesity issues [1] - Obesity is currently the sixth leading cause of death and disability in China, serving as a precursor to over 200 diseases, including diabetes and cardiovascular diseases [1] Group 3: Multidisciplinary Approach - The treatment of obesity requires a collaborative approach involving multiple disciplines such as endocrinology, nutrition, exercise medicine, psychology, and public health [3] - The blue paper emphasizes a tiered intervention strategy: lifestyle intervention, medication assistance, and surgical evaluation, along with the principle of rational medication use [2]

Overview - The diabetic foot treatment market in China is projected to reach CNY 214.14 billion in 2024, with a year-on-year growth of 3.67%. Medical services account for 82.4% of the market, while diabetic foot medications make up 17.6% [1][8] - The largest share of the diabetic foot medication market is held by chemical drugs at 9.0%, followed by wound dressings at 5.6% and biological products at 2.1% [1][8] - The increasing awareness of diabetes foot and the aging population are expected to further expand the market demand for diabetic foot treatment [1][8] Development History - Research on diabetic foot treatment in China began in the 1990s, with significant advancements in clinical diagnosis and treatment standards [4] - The introduction of multidisciplinary treatment models has improved diabetic foot management, and new technologies such as spinal cord stimulators have emerged as treatment options [4] Background - China has a significant number of diabetes patients, with 148 million diagnosed and an additional 274 million in the pre-diabetic stage. The diabetic foot is a severe complication affecting these patients [6] - The number of diabetic foot patients in China is expected to reach 8.3 million in 2024, reflecting a year-on-year increase of 2.47% [6] Current Market Status - The diabetic foot treatment market is expanding due to the large patient population, with a market size of CNY 214.14 billion projected for 2024 [8] - The demand for diabetic foot treatment is expected to grow as health knowledge improves and more patients seek timely medical care [8] Competitive Landscape - The diabetic foot treatment industry in China features a competitive landscape with both multinational and domestic companies. Multinational firms dominate the high-end market, while domestic companies focus on generic drugs and innovative drug development [10] - Key players in the market include companies like Innovent Biologics, East China Pharmaceutical, and Hengrui Medicine, which are involved in various segments of diabetic foot treatment [10][12][14] Future Trends - The future of diabetic foot treatment will see a more mature multidisciplinary collaboration model, enhancing treatment effectiveness and reducing amputation rates [16] - Increased focus on prevention and education for patients and their families is expected, along with regular screening for high-risk populations to mitigate the incidence and severity of diabetic foot [16]

Group 1 - The core viewpoint emphasizes that public hospitals must focus on high-quality development by enhancing technology, management, and services while ensuring public welfare and improving efficiency, ultimately transitioning from "scale expansion" to "value-based healthcare" [1] - The key strategies for cancer hospital discipline construction include focusing on "true needs," "full cycle," and "driving capability," which aim to align discipline development with public health needs, provide comprehensive services, and elevate regional cancer prevention and treatment levels [1] Group 2 - The importance of the Multidisciplinary Team (MDT) model in cancer treatment is highlighted, with a focus on creating a quantifiable and replicable system rather than relying on individual efforts. The establishment of a "lung cancer comprehensive diagnosis and treatment model" is shared as a successful example [2] - The MDT team structure is based on a "triangular" framework with fixed teams, clear roles, and a chief responsibility system, along with standardized processes and feedback mechanisms to enhance collaboration and patient care [2] Group 3 - The development of talent is crucial for advancing public hospital quality, with a focus on a closed-loop strategy of attracting, nurturing, utilizing, and retaining talent. This includes targeted recruitment, practical training, empowerment in research and clinical roles, and fostering a sense of mission among staff [3] - Future plans include establishing a major clinical research center for new cancer drugs in Southwest China, promoting standardized treatment for cancer pain in grassroots settings, and creating an intelligent diagnostic platform for cancer diseases to improve resource allocation [3]